Search Results - "AGAPE, Philippe"

Loss of Major Molecular Response As a Trigger for Restarting Tyrosine Kinase Inhibitor Therapy in Patients With Chronic-Phase Chronic Myelogenous Leukemia Who Have Stopped Imatinib After Durable Undetectable Disease by ROUSSELOT, Philippe, CHARBONNIER, Aude, ESCOFFRE-BARBE, Martine, GUERCI-BRESLER, Agnès, TULLIEZ, Michel, PROST, Stéphane, SPENTCHIAN, Marc, CAYUELA, Jean Michel, REIFFERS, Josy, CHOMEL, Jean Claude, TURHAN, Ali, GUILHOT, Joëlle, CONY-MAKHOUL, Pascale, GUILHOT, François, MAHON, François-Xavier, AGAPE, Philippe, NICOLINI, Franck E, VARET, Bruno, GARDEMBAS, Martine, ETIENNE, Gabriel, REA, Delphine, ROY, Lydia

“…More than half of patients with chronic-phase chronic myelogenous leukemia (CP-CML) in complete molecular response (CMR) experience molecular relapse after…”
Get full text

Real-world study of the efficacy and safety of belantamab mafodotin (GSK2857916) in relapsed or refractory multiple myeloma based on data from the nominative ATU in France: IFM 2020-04 study by Talbot, Alexis, Bobin, Arthur, Tabone, Léa, Lambert, Jérôme, Boccaccio, Catherine, Deal, Cécile, Petillon, Marie-Odile, Allangba, Olivier, Agape, Philippe, Arnautou, Pierre, Belkhir, Rakiba, Cailleres, Sylvie, Chaoui, Driss, Chrétien, Marie-Lorraine, Decaux, Olivier, Schulmann, Samantha, Frenzel, Laurent, Gastaud, Lauris, Huart, Antoine, Hulin, Cyrille, Karlin, Lionel, Laribi, Kamel, Le Calloch, Ronan, Lenain, Pascal, Macro, Margaret, Manier, Salomon, Montes, Lydia, Moreau, Stéphane, Moreau, Philippe, Morel, Véronique, Norwood, James, Piocelle, Frédérique Orsini, Perrot, Aurore, Pica, Gian Matteo, Rey, Philippe, Schmitt, Anna, Stoppa, Anne-Marie, Tiab, Mourad, Touzeau, Cyrille, Vidal, Valérie, Vignon, Marguerite, Vincent, Laure, Van De Wyngaert, Zoé, Zarnitsky, Charles, Kerbouche, Naima, Paka, Prani, Leleu, Xavier, Arnulf, Bertrand, Avet-Loiseau, Hervé

“…Belantamab mafodotin (BM) is an anti-BCMA antibody-drug conjugate (GSK2857916) that represents an alternative option in multiple myeloma. We sought to assess…”
Get full text

Progressive multifocal leukoencephalopathy: MRI findings in HIV-infected patients are closer to rituximab- than natalizumab-associated PML by Alleg, Manel, Solis, Morgane, Baloglu, Seyyid, Cotton, François, Kerschen, Philippe, Bourre, Bertrand, Ahle, Guido, Pruvo, Jean-Pierre, Leclerc, Xavier, Vermersch, Patrick, Papeix, Caroline, Maillart, Élisabeth, Houillier, Caroline, Chabrot, Cécile Moluçon, Claise, Béatrice, Malak, Sandra, Martin-Blondel, Guillaume, Bonneville, Fabrice, Caulier, Alexis, Marolleau, Jean-Pierre, Bonnefoy, Jérôme Tamburini, Agape, Philippe, Kennel, Céline, Roussel, Xavier, Chauchet, Adrien, De Seze, Jérôme, Fafi-Kremer, Samira, Kremer, Stéphane

“…Objectives To compare brain MRI findings in progressive multifocal leukoencephalopathy (PML) associated to rituximab and natalizumab treatments and HIV…”
Get full text

Isolated intraocular relapses of primary cerebral lymphomas: An LOC network study by Younan, Nadia, Soussain, Carole, Choquet, Sylvain, Cassoux, Nathalie, Touitou, Valérie, Schmitt, Anna, Chinot, Olivier, Oberic, Lucie, Damaj, Gandhi, Houot, Roch, Ghesquières, Hervé, Laribi, Kamel, Ahle, Guido, Taillandier, Luc, Paillassa, Jérôme, Gyan, Emmanuel, Jardin, Fabrice, Delwail, Vincent, Marolleau, Jean‐Pierre, Tempescul, Adrian, Agapé, Philippe, Bourniquel, Marie, Vacheret, Fabienne, Jdid, Ibrahim, Le Garff‐Tavernier, Magali, Malaise, Denis, Alentorn, Agusti, Xuan, Khê Hoang, Houillier, Caroline

“…Most relapses of primary central nervous system lymphoma (PCNSL) occur in the brain and are associated with a poor prognosis. Isolated intraocular relapses…”
Get full text

Reduced-dose WBRT as consolidation treatment for patients with primary CNS lymphoma: an LOC network study by Lesueur, Paul, Damaj, Gandhi, Hoang-Xuan, Khê, Roland, Virginie, Schmitt, Anna, Chinot, Olivier, Fabbro, Michel, Agapé, Philippe, Moluçon-Chabrot, Cécile, Chebrek, Safia, Alentorn, Agusti, Feuvret, Loic, Delgadillo, Daniel, Stefan, Dinu, Choquet, Sylvain, Nichelli, Lucia, Mokhtari, Karima, Mathon, Bertrand, Dureau, Sylvain, Soussain, Carole, Houillier, Caroline

“…The optimal consolidation strategy for primary central nervous system lymphoma (PCNSL) remains controversial. Preventing radio-induced neurotoxicity of…”
Get full text

Dasatinib and low-intensity chemotherapy in elderly patients with Philadelphia chromosome–positive ALL by Rousselot, Philippe, Coudé, Marie Magdelaine, Gokbuget, Nicola, Gambacorti Passerini, Carlo, Hayette, Sandrine, Cayuela, Jean-Michel, Huguet, Françoise, Leguay, Thibaut, Chevallier, Patrice, Salanoubat, Celia, Bonmati, Caroline, Alexis, Magda, Hunault, Mathilde, Glaisner, Sylvie, Agape, Philippe, Berthou, Christian, Jourdan, Eric, Fernandes, José, Sutton, Laurent, Banos, Anne, Reman, Oumedaly, Lioure, Bruno, Thomas, Xavier, Ifrah, Norbert, Lafage-Pochitaloff, Marina, Bornand, Anne, Morisset, Laure, Robin, Valérie, Pfeifer, Heike, Delannoy, Andre, Ribera, Josep, Bassan, Renato, Delord, Marc, Hoelzer, Dieter, Dombret, Herve, Ottmann, Oliver G.

“…Prognosis of Philadelphia-positive (Ph+) acute lymphoblastic leukemia (ALL) in the elderly has improved during the imatinib era. We investigated dasatinib,…”
Get full text

First Results of the Acsé Pembrolizumab Phase II in the Primary CNS Lymphoma (PCNSL) Cohort by Hoang-Xuan, Khe, Houot, Roch, Soussain, Carole, Blonski, Marie, Schmitt, Anna, Delwail, Vincent, Damaj, Gandhi Laurent, Ghesquieres, Herve, Peyrade, Frédéric, Tempescul, Adrian, Abraham, Julie, Agape, Philippe, Ahle, Guido, Baize, Nathalie, Bories, Pierre, Campello, Chantal, Gyan, Emmanuel, Jardin, Fabrice, Rey, Philippe, Choquet, Sylvain, Houillier, Caroline, Cassoux, Nathalie, Touitou, Valerie, Martin-Duverneuil, Nadine, Legrand, Frederic, Lamrani-Ghaouti, Assia, Querel, Ophelie, Hoog Labouret, Natalie, Simon, Clotilde, Chevret, Sylvie, Massard, Christophe

“…Background: AcSé Pembrolizumab is a Phase 2, open-label, single-arm, multi-cohort, multicentric study investigating the efficacy and safety of pembrolizumab…”
Get full text

Primary Diffuse Large B-Cell CNS Lymphoma over 80 Years: An Analysis of 110 Patients from the French Oculo-Cerebral Lymphoma (LOC) Network by Maarek, Alizee, Maucort-Boulch, Delphine, Houillier, Caroline, Chinot, Olivier, Bijou, Fontanet, Taillandier, Luc, Agape, Philippe, Houot, Roch, Boyle, Eileen, Molucon-Chabrot, Cecile, Rey, Philippe, Choquet, Sylvain, Tamburini Bonnefoy, Jerome, Jaccard, Arnaud, Ahle, Guido, Fabbro, Michel, Gac, Anne-Claire, Meniane, Jean-Come, Le Coz, Marie Francoise, Gyan, Emmanuel, Hoang-Xuan, Khe, Soussain, Carole, Ghesquieres, Herv

“…Introduction: in large unselected series, the median age of Primary CNS Lymphoma (PCNSL) patients (pts) is about 70 years. In one USA cancer registry study for…”
Get full text

A genome-wide association study identifies susceptibility loci for primary central nervous system lymphoma at 6p25.3 and 3p22.1: a LOC Network study by Labreche, Karim, Daniau, Mailys, Sud, Amit, Law, Philip J, Royer-Perron, Louis, Holroyd, Amy, Broderick, Peter, Went, Molly, Benazra, Marion, Ahle, Guido, Soubeyran, Pierre, Taillandier, Luc, Chinot, Olivier L, Casasnovas, Olivier, Bay, Jacques-Olivier, Jardin, Fabrice, Oberic, Lucie, Fabbro, Michel, Damaj, Gandhi, Brion, Annie, Mokhtari, Karima, Philippe, Cathy, Sanson, Marc, Houillier, Caroline, Soussain, Carole, Hoang-Xuan, Khê, Houlston, Richard S, Alentorn, Agusti

“…Primary central nervous system lymphoma (PCNSL) is a rare form of extra-nodal non-Hodgkin lymphoma. PCNSL is a distinct subtype of non-Hodgkin lymphoma, with…”
Get full text

Comparable humoral response after two doses of adjuvanted influenza A/H1N1pdm2009 vaccine or natural infection in allogeneic stem cell transplant recipients by Dhédin, Nathalie, Krivine, Anne, Le Corre, Nicole, Mallet, Alain, Lioure, Bruno, Bay, Jacques-Olivier, Rubio, Marie-Thérèse, Agape, Philippe, Thiébaut, Anne, Le Goff, Jérôme, Autran, Brigitte, Ribaud, Patricia

“…Highlights • 2 doses of vaccine induces a humoral response comparable to that triggered by natural infection after allogeneic transplant. • Seroprotection rate…”
Get full text

The French LOC Network for Primary CNS Lymphoma (PCNSL) Patients: What Can We Learn from a Large National Database? by Soussain, Carole, Houillier, Caroline, Ghesquieres, Herve, Soubeyran, Pierre, Chinot, Olivier, Taillandier, Luc, Houot, Roch, Ahle, Guido, Gyan, Emmanuel, Chabrot, Cécile, Moles, Marie-Pierre, Choquet, Sylvain, Agape, Philippe, Delwail, Vincent, Jardin, Fabrice, Brion, Annie, Damaj, Gandhi, Casanovas, Olivier, Fornecker, Luc Mathieu, Fabbro, Michel, Touitou, Valerie, Cassoux, Nathalie, Gressin, Remy, Tempescul, Adrian, Jaccard, Arnaud, Bourquard, Pascal, Morschhauser, Franck, Hoang-Xuan, Khê

“…Background The shared knowledge regarding management and outcome of PCNSL patients are usually based on results of clinical phase II studies that include…”
Get full text

Reply to J. Richter et al by Rousselot, Philippe, Charbonnier, Aude, Cony-Makhoul, Pascale, Agape, Philippe, Nicolini, Franck E, Varet, Bruno, Gardembas, Martine, Etienne, Gabriel, Réa, Delphine, Roy, Lydia, Escoffre-Barbe, Martine, Guerci-Bresler, Agnès, Tulliez, Michel, Prost, Stéphane, Spentchian, Marc, Cayuela, Jean Michel, Reiffers, Josy, Chomel, Jean Claude, Turhan, Ali, Guilhot, Joëlle, Guilhot, François, Mahon, François-Xavier

Get full text

Treatment of Advanced Systemic Mastocytosis with PKC412: The French Compassionate Use Programme Experience and Historical Comparison by Chandesris, Marie-Olivia, Damaj, Gandhi, Canioni, Danielle, Brouzes, Chantal, Cabaret, Laure, Hanssens, Katia, Durieu, Isabelle, Durupt, Stéphane, Besnard, Sophie, Beyne-Rauzy, Odile, Launay, David, Schiffmann, Aurélie, Niault, Mathilde, Ranta, Dana, Agape, Philippe, Faure, Cyrill, Chantepie, Sylvain P, Daguindau, Nicolas, Bourget, Philippe, Dubreuil, Patrice, Lortholary, Olivier, Hermine, Olivier

“…Background Advanced Systemic Mastocytosis (adSM) still have very poor prognosis. No standard of care is yet available. Midostaurin (PKC412) is a powerful TKI…”
Get full text

Fluctuating Values of Molecular Residual Disease (MRD) without Molecular Progression After Imatinib Discontinuation in Patients (pts) with Chronic Myeloid Leukemia (CML) Who Have Maintained Complete Molecular Response: Implications for Re-Treatment Criteria and Role of Prior Interferon Therapy. A Pilot Study of the French CML Group (FILMC) by Rousselot, Philippe, Makhoul, Pascale Cony, Rea, Delphine, Agape, Philippe, Nicolini, Franck E, Legros, Laurence, Tulliez, Michel, Roy, Lydia, Charbonnier, Aude, Guilhot, Joelle, Guilhot, Francois, Mahon, Francois-Xavier

“…Abstract 3781 We have reported the results of imatinib discontinuation in CML pts in complete molecular response (CMR) for more than 2 years under imatinib…”
Get full text

Loss Of Major Molecular Response As a Trigger For Restarting Tyrosine Kinase Inhibitor Therapy In CP-CML Patients Who Have Stopped Imatinib After Durable Undetectable Minimal Residual Disease by Rousselot, Philippe, Charbonnier, Aude, Cony-Makhoul, Pascale, Agape, Philippe, Nicolini, Franck E, Varet, Bruno R., Gardembas, Martine, Etienne, Gabriel, Rea, Delphine, Roy, Lydia, Escoffre-Barbe, Martine, Guerci-Bresler, Agnès, Tulliez, Michel, Prost, Stephane, Spentchian, Marc, Cayuela, Jean-Michel, Reiffers, Josy, Chomel, Jean Claude, Turhan, Ali G, Guilhot, Joelle, Guilhot, Francois, Mahon, Francois-Xavier

“…More than half of patients with chronic phase chronic myelogenous leukemia (CP-CML) in complete molecular response (CMR) experience molecular relapse after…”
Get full text

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment in Patients with De Novo Philadelphia Positive ALL Aged 55 and Over: Final Results of the EWALL-Ph-01 Study by Rousselot, Philippe, Coudé, Marie Magdeleine, Huguet, Françoise, Lafage, Marina, Leguay, Thibaut, Salanoubat, Celia, Witz, Francis, Alexis, Magda, Janvier, Maud, Hunault, Mathilde, Agape, Philippe, Berthou, Christian, Jourdan, Eric, Fernandes, José, Sutton, Laurent, Banos, Anne, Reman, Oumedaly, Lioure, Bruno, Cayuela, Jean-Michel, Hayette, Sandrine, Gokbuget, Nicola, Hoelzer, Dieter, Delannoy, Andre, Gambacorti-Passerini, Carlo, Bassan, Renato, Ribera, Josep-Maria, Giebel, Sebastian, Dombret, Herve, Ottmann, Oliver G.

“…Abstract 666 Dasatinib (Sprycel®, Bristol-Myers Squibb) is a potent multi-targeted kinase inhibitor (TKI) of BCR-ABL and SRC family kinases. The EWALL group…”
Get full text

Management and outcome of primary CNS lymphoma in the modern era: An LOC network study by Houillier, Caroline, Soussain, Carole, Ghesquières, Hervé, Soubeyran, Pierre, Chinot, Olivier, Taillandier, Luc, Lamy, Thierry, Choquet, Sylvain, Ahle, Guido, Damaj, Gandhi, Agapé, Philippe, Moluçon-Chabrot, Cécile, Amiel, Alexandra, Delwail, Vincent, Fabbro, Michel, Jardin, Fabrice, Chauchet, Adrien, Moles-Moreau, Marie-Pierre, Morschhauser, Franck, Casasnovas, Olivier, Gressin, Rémy, Fornecker, Luc-Matthieu, Abraham, Julie, Marolleau, Jean-Pierre, Tempescul, Adrian, Campello, Chantal, Colin, Philippe, Tamburini, Jérôme, Laribi, Kamel, Serrier, Caroline, Haioun, Corinne, Chebrek, Safia, Schmitt, Anna, Blonski, Marie, Houot, Roch, Boyle, Eileen, Bay, Jacques-Olivier, Oberic, Lucie, Tabouret, Emeline, Waultier, Agathe, Martin-Duverneuil, Nadine, Touitou, Valérie, Cassoux, Nathalie, Kas, Aurélie, Mokhtari, Karima, Charlotte, Frederic, Alentorn, Agusti, Feuvret, Loïc, Le Garff-Tavernier, Magali, Costopoulos, Myrto, Mathon, Bertrand, Peyre, Matthieu, Delgadillo, Daniel, Douzane, Hassen, Genet, Diane, Aidaoui, Bachir, Hoang-Xuan, Khê, Gyan, Emmanuel

“…OBJECTIVEReal-life studies on patients with primary CNS lymphoma (PCNSL) are scarce. Our objective was to analyze, in a nationwide population-based study, the…”
Get full text

Response to Adjuvanted Monovalent Influenza A (H1N1)v Vaccine In Allogeneic Hematopoietic Stem Cell Transplant Recipients by Dhedin, Nathalie, Bay, Jacques-Olivier, Ribaud, Patricia, Coudert, Mathieu, Rubio, Marie T, Agape, Philippe, Thiebaut, Anne, Garnier, Alice, Faugeras, Aurelie, Lecorre, Nicole, Uzunov, Madalina, Kerbi-Hamimed, Nabila, Socié, Gérard, Milpied, Noel, Autran, Brigitte, Krivine, Anne

“…Abstract 1269 Influenza is a potentially serious infection after hematopoietic stem cell transplantation (HSCT). Prolonged immunosuppression leads to impaired…”
Get full text

Isolated intra-ocular relapses of primary central nervous system lymphoma by Younan, Nadia, Soussain, Carole, Choquet, Sylvain, Touitou, Valérie, Schmitt, Anna, Chinot, O., Taillandier, Luc, Amiel, Alexandra, Laribi, Kamel, Lamy, Thierry, Ghesquieres, Hervé, Marolleau, Jean-Pierre, Moles-Moreau, Marie-Pierre, Tempescul, Adian, Agape, Philippe, Cassoux, Nathalie, Jardin, Fabrice, Gressin, Rémy, Gyan, Emmanuel, Brion, A., Ahle, Guido, El Yamani, Abderrazak, Bourniquel, Marie, Hoang-Xuan, Khê, Houillier, Caroline

“…Background and aims: Relapses in primary central nervous system lymphoma (PCNSL) are usually cerebral and severe. Isolated intraocular relapses (IIOR) are much…”
Get full text

Dasatinib (Sprycel®) and Low Intensity Chemotherapy for First-Line Treatment In Elderly Patients with De Novo Philadelphia Positive ALL (EWALL-PH-01): Kinetic of Response, Resistance and Prognostic Significance by Rousselot, Philippe, Cayuela, Jean Michel, Hayette, Sandrine, Récher, Christian, Leguay, Thibaut, Salanoubat, Celia, Witz, Francis, Alexis, Magda, Hunault, Mathilde, Janvier, Maud, Agape, Philippe, Berthou, Christian, Jourdan, Eric, Fernandes, José, Sutton, Laurent, Banos, Anne, Reman, Oumedaly, Lioure, Bruno, Thomas, Xavier, Ifrah, Norbert, Gokbuget, Nicola, Hoelzer, Dieter, Delannoy, Andre, Bassan, Renato, Ribera, Jose M., Giebel, Sebastian, Dombret, Herve, Ottmann, Oliver G.

“…Abstract 172 Dasatinib (Sprycel®) is a potent inhibitor of BCR-ABL and SRC family kinases. Based on the rapid and clinically meaningful activity observed when…”
Get full text